Suppliers / Curia France Sas

Curia France Sas

France Updated 9 July 2026

The public registers hold a second record for Curia France Sas. The fuller profile, with 116 active US DMFs and 8 valid CEPs, is at Curia. Figures on this page cover only this record.

Curia France Sas is an API manufacturer based in France. It holds 2 active US drug master files. Its most recent recorded inspection, by US FDA, closed on 3 March 2022 as VAI.

2
active US DMFs
0
valid CEPs
2
registered plants 2 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 3 March 2022 VAI US FDA
  • 8 October 2021 VAI US FDA
  • 17 January 2019 VAI US FDA
  • 18 November 2014 NAI US FDA
  • 13 November 2014 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
France, France 3006257961
France, France 3009615607

What they file, and where

Molecule Regulators Docs
Aztreonam US FDA 2

Also appears on these molecule pages

Aztreonam API

Questions about Curia France Sas

Does Curia France Sas hold a US DMF or a CEP?
Curia France Sas holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Curia France Sas FDA-registered?
2 sites operated by Curia France Sas carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Curia France Sas's last inspection go?
The most recent inspection on record closed on 3 March 2022 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 5 inspections are on file.
Where does Curia France Sas manufacture?
2 registered sites are on record, in France (France among others). Every site is listed on this page with the register it came from.
What does Curia France Sas make?
1 molecule is on record against Curia France Sas, including Aztreonam. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Curia France Sas comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 3 March 2022.

Comparable suppliers

Apitoria Pharma shares 1 molecule Fresenius Kabi shares 1 molecule Guang'An Kingday Pharma And Chem shares 1 molecule Chongqing Shenghuaxi Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability